AstraZeneca—Summary judgment granted

Defended AstraZeneca in claims of more than one billion in damages for breach of contract and theft of trade secrets. Ocimum claimed that AstraZeneca wrongfully retained data after their agreement had ended in 2004. Agreeing with our argument that Ocimum ignored its suspicion that AstraZeneca had breached the contract for six years, the court granted our request for summary judgment based on the statute of limitations.